May 26, 2009 | Press ReleaseSciformix Corporation Expands Executive Team with Appointment of Dr. Sidney N. Kahn
Industry Veteran Joins Company’s Pharmacovigilance Practice
WESTBOROUGH, Mass. – May 26, 2009 – Sciformix Corporation, a leading provider of knowledge process outsourcing (KPO) services for the pharmaceutical and biotechnology industries, today announced the appointment of Dr. Sidney N. Kahn to its executive team. A well-known industry expert in drug safety, Dr. Kahn previously served on the Sciformix Scientific Advisory Board and now, in his new role, will lead the company’s Pharmacovigilance practice.
“We welcome Sidney as a member of our management team,” said Dinesh Thakur, president & CEO of Sciformix. “Given the growth and focus in the Pharmacovigilance and risk management area for us, having someone of his experience and knowledge provides a compelling value proposition to our customers”.
Dr. Kahn brings many years of deep experience in drug safety & risk management to the company. After 17 years in academia in the UK and USA, Dr. Kahn spent 13 years at Bristol-Myers Squibb and Johnson & Johnson managing safety assessment and risk management organizations for medicines throughout their lifecycle before establishing his own pharmacovigilance consulting practice in 2002. He was actively involved in multiple global pharmacovigilance initiatives, including several ICH EWGs, the CIOMS-VI WG, the HL7 SPL Implementation WG, and DIA SIACs for Labeling, Clinical Safety and Pharmacovigilance, and Terminology Management. He holds an MB, ChB (Cape Town), a Ph. D. (London), specialist certification by the Royal College of Pathologists, and membership of the Faculty of Pharmaceutical Medicine, UK.
“I am delighted to be able to take a more active, hands-on role in the management of Sciformix’s Pharmacovigilance KPO”, said Dr. Kahn. “Sciformix offers pharmaceutical companies unequalled Pharmacovigilance outsourcing services through its deployment of skilled, knowledgeable personnel to deliver the highest quality safety products, including not only full compliance with regulatory reporting obligations but also comprehensive aggregate reporting and safety evaluation of products throughout their life cycle.”
About Sciformix Corporation
Founded in 2006, Sciformix is a knowledge process outsourcing (KPO) provider that delivers its services leveraging a global delivery model. Headquartered in Westborough, MA, its service delivery centers are located in Mumbai and Pune, India. Sciformix specializes in providing pharmacovigilance & risk management, biostatistics & programming, medical writing and regulatory writing services to the pharmaceutical and biotechnology industries. The company is privately-funded by Flybridge Capital Partners. For more information, please visit www.sciformix.com
Vice President - Business Development